• Info
  • Insider Ownership

Insider Trading & Ownership of Daniel E. Geffken

Location
Concord, MA
Summary
The estimated net worth of Daniel E. Geffken is at least $138,238 dollars as of 20 May 2024. Daniel E. Geffken is the Chief Financial Officer of PHOENIX BIOTECH ACQUISITION CORP. and owns shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO) stock worth about $100K. Daniel E. Geffken is the INTERIM CFO of Eloxx Pharmaceuticals, Inc. and owns shares of Eloxx Pharmaceuticals, Inc. stock worth about $36K. Daniel E. Geffken is the Director of WINDTREE THERAPEUTICS INC /DE/ and owns shares of WINDTREE THERAPEUTICS INC /DE/ (WINT) stock worth about $2.2K.
Signature
/s/ John Dunn, Esq., Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Daniel E. Geffken files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Daniel E. Geffken

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CERO, CEROW CERO THERAPEUTICS HOLDINGS, INC. Chief Financial Officer $100,020 14 Feb 2024
ELOX Eloxx Pharmaceuticals, Inc. Interim Cfo $36,000 29 Nov 2021
WINT, WINTW WINDTREE THERAPEUTICS INC /DE/ Director $2,218 23 Aug 2023
CALC CalciMedica, Inc. Interim CFO 17 May 2024
PMN ProMIS Neurosciences Inc. Chief Financial Officer 26 Oct 2023

Insider Transactions Reported by Daniel E. Geffken:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.